Table 1 Comparison with previous studies.

From: A high-generalizability machine learning framework for predicting the progression of Alzheimer’s disease using limited data

Method

Dataset

Input

Period

Accuracy

AUC

Sensitivity

Specificity

DNN [7]

NA-ADNI

MRI, FDG-PET

3 years

0.83

0.80

0.84

DNN [8]

NA-ADNIa

MRI

3 years

0.75

0.75

0.75

DNN [9]

NA-ADNI

MRI

1.5 yearsb

0.79

0.75

0.82

DNN [10]

NA-ADNI

MRI

3 years

0.83c

0.88c

0.76c

0.87c

SVM [11]

NA-ADNI

MRI, Cognitive scores

3 years

0.85

0.47

0.97

Random forest[12]

NA-ADNI

MRI, gender, age

1 year

0.79

0.82

0.74

SVM [13]

NA-ADNI

MRI, MMSE

3 yearsb

0.85d

0.90d

0.84d

0.88d

DNN [14]

NA-ADNIa

MRI, Cognitive scores, age

Series

0.76

DNN [15]

NA-ADNI

MRI, Cognitive scores, CSF, demographics

1 year

0.81

0.84

0.80

DNN [16]

NA-ADNI

MRI, Cognitive scores, APOE, gender, age

1 year

0.86e

0.82e

0.88e

Random forest[17]

NA-ADNI

MRI, PET, Cognitive scores, APOE

3 years

0.87 f

0.87 f

0.86 f

Proposed (M2)

NA-ADNI

MRI

2 years

0.78

0.85

0.78

0.78

Proposed (M5)

NA-ADNI

MRI, Cognitive scores, APOE, age

2 years

0.88

0.95

0.88

0.88

  1. aRelatively small datasets compared with the NA-ADNI were also used for both training and evaluation.
  2. bFollow-up periods used for sMCI are longer than that of pMCI (5 years in DNN [9] and 4 years in SVM [13]).
  3. cTrained with mixed groups of NC+sMCI and pSMI+AD.
  4. dtwofold validation accuracy.
  5. eTenfold cross-validation accuracy.
  6. fTenfold cross-validation accuracy, much higher accuracy of 91% on a small hold out test set.